Understanding Experiences and Needs of Patients With Prostate Cancer Across Asia-Pacific: A Cross-Sectional Mixed-Methods Study

Author:

Tran Ben123,Mizokami Atsushi4,Wang Shian-Shiang5,Li Yonghong678,Takeuchi Tsutomu9,Bain Paul10,Liu Yiting11,Maeng Chan Young12,Singh Anildeep13,Kishiwada Naomi13,Cheng Marie Simone13,Gowindah Regina14ORCID,Si Jennifer14,Han Hyunho15

Affiliation:

1. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

2. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

3. Division of Personalised Oncology, Walter and Eliza Hall Institute, Parkville, Australia

4. Department of Integrative Cancer Therapy and Urology, Kanazawa University, Graduate School of Medical Science, Kanazawa, Japan

5. Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan (ROC)

6. State Key Laboratory of Oncology, Guangzhou, Guangdong, China

7. Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong, China

8. Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China

9. NPO Japan Prostate Cancer Patients Association, Hyogo, Japan

10. Prostate Cancer Foundation of Australia, St Leonards NSW, Australia

11. Mi-Jian Patient Community/MeetHealth, Xiamen, China

12. Prostate Cancer Patients Association, Seoul, Republic of Korea

13. Johnson & Johnson International (Singapore) Pte. Ltd., Singapore, Singapore

14. Oracle Life Sciences, Singapore, Singapore

15. Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea

Abstract

Purpose: To understand the impact of prostate cancer (PC) and identify gaps in existing care from patients, caregivers, and physicians in Australia, Japan, Mainland China, South Korea, and Taiwan. Materials and Methods: This study comprised qualitative interviews among patient-caregiver pairs and quantitative surveys among patients (high-risk localized [HRLPC] or metastatic castration-resistant [mCRPC]) and physicians. Thematic interpretation from qualitative interviews, to facilitate the quantitative survey development, was guided by the Psycho-Onco Emotional Anxiety (POEM) Framework and COM-B (Capability, Opportunity, Motivation-Behavior) model. Results: Patients reported experiencing high anxiety about fear of cancer recurrence (HRLPC: 83.3%; mCRPC: 88.9%), which increased along the course of their illness (68.8%; 48.1%). More mCRPC (40.7%) than HRLPC (20.8%) patients perceived delays in cancer diagnosis, with reasons related to time between consultation and diagnosis, belief that symptoms were not severe, prostate-specific antigen testing not a routine, or unaware of symptoms. More mCRPC (25.9%) than HRLPC (8.3%) were confused about treatment options, consistent with physicians' clinical observations. More mCRPC than HRLPC patients felt their physicians did not clearly explain potential treatment benefits, risks, and side effects or inform new therapies. Physicians (39.4%-49.5%) reported having insufficient consultation time to talk to patients. Despite majority of physicians (>80%) encouraging patients to make treatment decisions, 77.8% to 83.3% of patients relied on their doctors. Conclusions: Challenges to current PC care included gaps in knowledge, patient-physician communication, shared decision-making, and psychosocial support which are interrelated. There is a need for multidisciplinary efforts to boost patient awareness and psychosocial support to enhance the quality of comprehensive PC care.

Funder

Johnson & Johnson International (Singapore) Pte. Ltd

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3